Position in VKTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,406,000
+$3,184,017 QoQ
Shares Held
600,000
-3.5% QoQ
Ownership
0.514%
of shares outstanding
% of Portfolio
5.82%
of 13F equity value
Holder Rank
#26
of 435 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Derivatives in VKTX
reported options exposure · as of Jun 30, 2026CallValue
$9,752,500
CallShares
250,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BlackBarn Capital Partners LP holds $106,186,000 across 3 Biotechnology names. VKTX ranks #2 (22.0% of the industry book) .
All Filings in VKTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,406,000 | 600,000 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $9,752,500 | 250,000 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $20,221,983 | 621,450 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,349,000 | 550,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,140,000 | 500,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,275,000 | 350,000 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||